IN THE NEWS | Oceanit’s ASSURE-100 in Honolulu Civil Beat
Oceanit recently spoke with Civil Beat journalist, Eleni Avendaño, about the ongoing trials and development of ASSURE rapid tests. Oceanit’s ASSURE is currently in clinical trials in multiple locations as the rapid tests advance towards submission to the U.S. FDA…
Read moreLooking Back on 2020 at Oceanit
Nobody, including Oceanit, expected 2020 to be the chaotic and surreal a year that it was. In our 35 years in business, the Oceanit family has not experienced a local and global situation like this. From the global pandemic to incomplete or absent leadership and government policies, there were many reasons to be pessimistic.…
Read moreIN THE NEWS | Oceanit News Update October 20th
Oceanit continues to earn local and national media coverage for our work during the ongoing global pandemic; both in direct response to our ASSURE-19 rapid saliva test development and on our efforts to help Hawai’i rebuild stability and sustainability in…
Read morePRESS RELEASE | National Institutes of Health approves next round of ASSURE-19 funding under the RADx ‘Next’ program
Honolulu, HI | Oceanit Laboratories received approval from NIH for next round funding under the RADx initiative, receiving an additional $250,000 for further development of the ASSURE-19 rapid Covid-19 saliva test. With this latest round of funding, Oceanit will have…
Read moreIN THE NEWS | The call for rapid, point-of-need Covid-19 testing
In an opinion piece for the Civil Beat Ideas Section, State Representatives, Bob McDermott (House District 4: Ewa, Ewa Beach, Ewa Gentry and Iroquois Point) and Gene Ward (Hawaii House Minority Leader) called for CARES Act funds to be applied…
Read moreIN THE NEWS | The Aloha Protocol for a safer reopening with ASSURE-19
As Oceanit moves ahead with in-vitro and in-vivo testing for the ASSURE-19 rapid point-of-need test kits, Hawaii is seeing high, sustained counts for new covid-19 cases each day. Oahu reentered lockdown last week with the U.S Surgeon General, Jerome Adams…
Read more